ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

April 27, 2007

In Brief: David Chambers named deputy director for implementation science at NCI DCCPS

December 5, 2014

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

November 28, 2014